Skip to main navigation
Allogene Therapeutics
Contact Us
Careers
SHARE
Email Us
Print
Allogene Therapeutics
  • Pipeline
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • Science
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-demand Availability
    • SCIENTIFIC PUBLICATIONS
  • About Us
    • At A Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • News Center
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • IR Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents and Charters
      • Board of Directors
      • Management
      • Committee Composition
    • SEC Filings
    • Resources
      • Investor FAQs
      • Email Alerts
      • IR Inquiry

SEC Filing Details

SEC Filing Details

Document Details

Form
SCHEDULE 13G/A
Filing Date
Aug 8, 2025
Document Date
Aug 8, 2025
Form Description
SCHEDULE 13G/A - Description
Filing Group
Other
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Email Alerts
RSS Feeds
Investor Contacts
Facebook
Twitter
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene Therapeutics
CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

  • Pipeline
  • AlloCAR T Product Pipeline
  • THE ALPHA3 TRIAL
  • THE RESOLUTION TRIAL
  • DATABRIEF
  • Expanded Access
  • Science
  • Next Revolution in Cell Therapy
  • Platform for Tomorrow
  • On-Demand Availability
  • Scientific Publications
  • About Us
  • At a Glance
  • Management Team
  • Board of Directors
  • Scientific Advisors
  • Partners
  • Corporate Responsibility
  • News Center
  • Press Releases
  • Events
  • Perspectives
  • Social Media
  • Community Guidelines
  • Investors
  • Press Releases
  • Events
  • Presentations
  • Stock Information
  • Stock Quote & Chart
  • Historical Price Look Up
  • Investment Calculator
  • Corporate Governance
  • Documents & Charters
  • Board of Directors
  • Management
  • Committee Composition
  • SEC Filings
  • Resources
  • Investor FAQs
  • Email Alerts
  • IR Inquiry
©2026 Allogene Therapeutics
TERMS OF USE
PRIVACY NOTICE